Walleye Capital’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 1859 |
|
|
2025
Q1 | – | Sell |
-22,224
| Closed | -$160K | – | 1806 |
|
|
2024
Q4 | $160K | Buy |
+22,224
| New | +$160K | ﹤0.01% | 1573 |
|
|
2024
Q3 | – | Sell |
-23,000
| Closed | -$153K | – | 2455 |
|
|
2024
Q2 | $153K | Sell |
23,000
-11,813
| -34% | -$78.6K | ﹤0.01% | 1938 |
|
|
2024
Q1 | $354K | Buy |
34,813
+11,206
| +47% | +$114K | ﹤0.01% | 1560 |
|
|
2023
Q4 | $266K | Buy |
+23,607
| New | +$266K | ﹤0.01% | 1392 |
|
|
2023
Q3 | – | Sell |
-419,783
| Closed | -$1.48M | – | 2241 |
|
|
2023
Q2 | $1.48M | Buy |
419,783
+372,544
| +789% | +$1.32M | 0.01% | 605 |
|
|
2023
Q1 | $199K | Buy |
+47,239
| New | +$199K | ﹤0.01% | 1328 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 2107 |
|
|
2022
Q3 | – | Sell |
-134,993
| Closed | -$1.58M | – | 2258 |
|
|
2022
Q2 | $1.58M | Sell |
134,993
-76,760
| -36% | -$898K | 0.04% | 432 |
|
|
2022
Q1 | $1.29M | Buy |
211,753
+139,449
| +193% | +$850K | 0.03% | 492 |
|
|
2021
Q4 | $662K | Buy |
+72,304
| New | +$662K | 0.02% | 788 |
|